A registry study led by the University of Oulu examined the early-stage treatment of relapsing-remitting multiple sclerosis ...

Dr Annalisa Morgan previews discussions on disease-modifying therapies, emerging treatments such as CAR T-cell therapy, and ...

Again, the total cost was mainly composed of indirect costs. In Sweden, the economic burden of MS was evaluated by a cost-of-illness study using a top-down approach of costing. The annual ...

A low educational status was associated with longer delays before initiating treatment among relapsing-remitting MS patients ...

There are relapsing-remitting and progressive types of MS, but the course is rarely predictable. Researchers still don’t fully understand the cause of MS or why the rate of progression is so ...

Scientists interviewed 17 patients who reported feeling unmoored by a disease that has stripped away their sense of control ...